These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25854537)

  • 1. TALOS: a multicenter, randomized, double-blind, placebo-controlled trial to test the effects of citalopram in patients with acute stroke.
    Kraglund KL; Mortensen JK; Grove EL; Johnsen SP; Andersen G
    Int J Stroke; 2015 Aug; 10(6):985-7. PubMed ID: 25854537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroregeneration and Vascular Protection by Citalopram in Acute Ischemic Stroke (TALOS).
    Kraglund KL; Mortensen JK; Damsbo AG; Modrau B; Simonsen SA; Iversen HK; Madsen M; Grove EL; Johnsen SP; Andersen G
    Stroke; 2018 Nov; 49(11):2568-2576. PubMed ID: 30355209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial.
    Savadi Oskouie D; Sharifipour E; Sadeghi Bazargani H; Hashemilar M; Nikanfar M; Ghazanfari Amlashi S; Abbaszade Z; Sadeghihokmabadi E; Rikhtegar R; Golzari SEJ
    Neurorehabil Neural Repair; 2017 Jul; 31(7):638-647. PubMed ID: 28454498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet effects of citalopram in patients with ischaemic stroke: A randomized, placebo-controlled, double-blind study.
    Kraglund KL; Mortensen JK; Johnsen SP; Andersen G; Grove EL
    Sci Rep; 2019 Dec; 9(1):20048. PubMed ID: 31882732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
    Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP).
    Thomalla G; Fiebach JB; Østergaard L; Pedraza S; Thijs V; Nighoghossian N; Roy P; Muir KW; Ebinger M; Cheng B; Galinovic I; Cho TH; Puig J; Boutitie F; Simonsen CZ; Endres M; Fiehler J; Gerloff C;
    Int J Stroke; 2014 Aug; 9(6):829-36. PubMed ID: 23490032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation.
    Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK
    Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-term Outcome after Acute Ischemic Stroke.
    Siepmann T; Kepplinger J; Zerna C; Schatz U; Penzlin AI; Pallesen LP; Illigens BM; Weidner K; Reichmann H; Puetz V; Bodechtel U; Barlinn K
    J Stroke Cerebrovasc Dis; 2015 Aug; 24(8):1886-92. PubMed ID: 26099557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Optimal Neuroprotection of neu2000 in acute Ischemic stroke with reCanalization: study protocol for a randomized, double-blinded, placebo-controlled, phase-II trial.
    Hong JM; Choi MH; Sohn SI; Hwang YH; Ahn SH; Lee YB; Shin DI; Chamorro Á; Choi DW;
    Trials; 2018 Jul; 19(1):375. PubMed ID: 30005644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study.
    Mortensen JK; Larsson H; Johnsen SP; Andersen G
    Stroke; 2013 Feb; 44(2):420-6. PubMed ID: 23306326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design to assess the efficacy and safety of HT047 in patients with acute ischemic stroke: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase II trial.
    Heo SH; Song J; Kim BJ; Kim H; Chang DI;
    Medicine (Baltimore); 2019 Oct; 98(43):e17655. PubMed ID: 31651889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effıcacy of cıtalopram on stroke recurrence: A randomızed clınıcal trıal.
    Ece Çetin F; Kumral E; Saffet Gönül A; Nezih Özdemir H; Orman M
    J Clin Neurosci; 2022 Jul; 101():168-174. PubMed ID: 35597066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
    Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
    Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging agents for the treatment and prevention of stroke: progress in clinical trials.
    Safouris A; Magoufis G; Tsivgoulis G
    Expert Opin Investig Drugs; 2021 Oct; 30(10):1025-1035. PubMed ID: 34555978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy comparison of citalopram, fluoxetine, and placebo on motor recovery after ischemic stroke: a double-blind placebo-controlled randomized controlled trial.
    Asadollahi M; Ramezani M; Khanmoradi Z; Karimialavijeh E
    Clin Rehabil; 2018 Aug; 32(8):1069-1075. PubMed ID: 29783900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter gene polymorphisms may be associated with poststroke neurological recovery after escitalopram use.
    Lee EJ; Oh MS; Kim JS; Chang DI; Park JH; Cha JK; Heo JH; Sohn SI; Kim DE; Kim HY; Kim J; Seo WK; Lee J; Park SW; Kim YJ; Lee BC;
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):271-276. PubMed ID: 29030421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice.
    Espinera AR; Ogle ME; Gu X; Wei L
    Neuroscience; 2013 Sep; 247():1-11. PubMed ID: 23590907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.
    Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH
    J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial.
    Gharagozli K; Harandi AA; Houshmand S; Akbari N; Muresanu DF; Vester J; Winter S; Moessler H
    J Med Life; 2017; 10(3):153-160. PubMed ID: 29075343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.